LifeLabs, Contextual to Co-market, Sell Genetic Tests in Canada | GenomeWeb

NEW YORK (GenomeWeb News) – LifeLabs Medical Laboratory Services and Contextual Genomics today announced a deal to broaden the availability of Contextual's genetic and genomic tests in Canada.

Under the terms of the agreement, the companies will co-market and sell Contextual's genetic tests for cancer and other conditions to patients and doctors in Canada. Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.